| Intangible Asset and Goodwill [Text Block] |
Note 5. Goodwill and Intangible Assets
Intangible assets other than goodwill consisted of the following:
| | | June 30, 2026 | | | March 31, 2026 | |
| | | Gross Carrying Amount | | | Accumulated Amortization | | | Net Carrying Amount | | | Gross Carrying Amount | | | Accumulated Amortization | | | Net Carrying Amount | |
| Customer relationships | | $ | 186,827 | | | $ | (127,233 | ) | | $ | 59,594 | | | $ | 188,192 | | | $ | (124,981 | ) | | $ | 63,211 | |
| Other intangibles | | | 59,975 | | | | (41,167 | ) | | | 18,808 | | | | 60,308 | | | | (40,172 | ) | | | 20,136 | |
| Total finite-lived intangible assets | | $ | 246,802 | | | $ | (168,400 | ) | | $ | 78,402 | | | $ | 248,500 | | | $ | (165,153 | ) | | $ | 83,347 | |
Amortization expense for intangible assets was as follows:
| | | Three Months Ended June 30, | |
| | | 2026 | | | 2025 | |
| Amortization in cost of revenue | | $ | 691 | | | $ | 702 | |
| Amortization in general and administrative | | | 3,701 | | | | 3,851 | |
| Total | | $ | 4,392 | | | $ | 4,553 | |
Estimated future amortization expense for the following fiscal years ending March 31 is presented below, based on foreign currency exchange rates in effect as of June 30, 2026:
| Fiscal Year | | Amortization Expense | |
| Remainder of 2027 | | $ | 12,726 | |
| 2028 | | | 16,389 | |
| 2029 | | | 15,832 | |
| 2030 | | | 11,217 | |
| 2031 | | | 4,829 | |
The change in the carrying amount of goodwill was as follows:
| | | Sterilization and Disinfection Control | | | Biopharmaceutical Development | | | Calibration Solutions | | | Clinical Genomics | | | Total | |
| March 31, 2026 | | $ | 82,810 | | | $ | 49,666 | | | $ | 37,266 | | | $ | 17,121 | | | $ | 186,863 | |
| Effect of foreign currency translation | | | (273 | ) | | | (585 | ) | | | (6 | ) | | | 39 | | | | (825 | ) |
| June 30, 2026 | | $ | 82,537 | | | $ | 49,081 | | | $ | 37,260 | | | $ | 17,160 | | | $ | 186,038 | |
|